Brief: UroGen Announces New Data Presentations at the Society of Urologic Oncology 2024 Annual Meeting Highlighting Urothelial Cancer Portfolio Aimed at Addressing Unmet Needs
02/12/2024 13:22
Dec 2 (Reuters) - Urogen Pharma Ltd UR8.F :
* UROGEN ANNOUNCES NEW DATA PRESENTATIONS AT THE SOCIETY OF
UROLOGIC ONCOLOGY 2024 ANNUAL MEETING HIGHLIGHTING UROTHELIAL
CANCER PORTFOLIO AIMED AT ADDRESSING UNMET NEEDS
Source text: ID:nBw1PZ5ma
Further company coverage: UR8.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on UroGen Pharma
See all newsBrief: Urogen Submits NDA For Ugn-103, An Investigational Treatment Of Recurrent Lg-Ir-Nmibc
Reports 36-Month Duration Of Response Of 64.5% For ZUSDURI In Phase 3 Envision Trial
Brief: Journal Of Urology Publishes Envision Trial Results Showing 72.2% 24-Month Duration Of Response With Zusduri
Brief: Urogen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Urogen Announces Refinanced Term Loan Agreement With Pharmakon Advisors